{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:45:13Z","timestamp":1778694313717,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.phymed.2006.03.012","type":"journal-article","created":{"date-parts":[[2006,9,15]],"date-time":"2006-09-15T08:14:11Z","timestamp":1158308051000},"page":"51-55","source":"Crossref","is-referenced-by-count":43,"special_numbering":"S1","title":["Binding of STW 5 (Iberogast\u00ae) and its components to intestinal 5-HT, muscarinic M3, and opioid receptors"],"prefix":"10.1016","volume":"13","author":[{"given":"U.","family":"Simmen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Kelber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.N.","family":"Okpanyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Jaeggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Bueter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Weiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2006.03.012_bib15","doi-asserted-by":"crossref","unstructured":"Allescher, H., 2006. Functional dyspepsia \u2013 a multi-causal disease and its therapy. Phytomedicine, this issue.","DOI":"10.1016\/j.phymed.2006.05.001"},{"key":"10.1016\/j.phymed.2006.03.012_bib16","doi-asserted-by":"crossref","unstructured":"Ammon, H.P.T., Kelber, O., Okpanyi, S.N., 2006. Spasmolytic and tonic effect of Iberogasts (STW 5) in intestinal smooth muscle. Phytomedicine, this issue.","DOI":"10.1016\/j.phymed.2006.08.004"},{"key":"10.1016\/j.phymed.2006.03.012_bib1","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1053\/gast.2002.35990","article-title":"Condition-specific deactivation of brain regions by 5-HT3 receptor antagonist Alosetron","volume":"123","author":"Berman","year":"2002","journal-title":"Gastroenterology"},{"issue":"Suppl.","key":"10.1016\/j.phymed.2006.03.012_bib2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00004836-200207001-00011","article-title":"Irritable bowel syndrome neuropharmacology. A review of approved and investigational compounds","volume":"35","author":"Callahan","year":"2002","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.phymed.2006.03.012_bib3","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/sj.bjp.0705741","article-title":"Treating irritable bowel syndrome: overview, perspective and future therapies","volume":"141","author":"Chamilleri","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phymed.2006.03.012_bib4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1046\/j.1365-2036.1997.00189.x","article-title":"Zamifenacin (UK-76, 654) a potent gut M3 selective muscarinic antagonist, reduces colonic motor activity in patients with irritable bowel syndrome","volume":"11","author":"Houghton","year":"1997","journal-title":"Aliment Pharmacol. Ther."},{"key":"10.1016\/j.phymed.2006.03.012_bib5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-2036.2002.01185.x","article-title":"The complexity of drug development for irritable bowel syndrome","volume":"16","author":"Kamm","year":"2002","journal-title":"Aliment Pharmacol. Ther."},{"key":"10.1016\/j.phymed.2006.03.012_bib6","doi-asserted-by":"crossref","unstructured":"Kelber, O., Wittwer, A., Lapke, C., Weiser, D, Okpanyi, S.N., Heilmann, J., 2006. Absorption of STW 5 (Iberogast) and its components ex vivo\/in vitro. Phytomedicine, this issue.","DOI":"10.1016\/j.phymed.2006.07.002"},{"key":"10.1016\/j.phymed.2006.03.012_bib7","doi-asserted-by":"crossref","unstructured":"Khayyal, M.T., Seif-El-Nasr, M., El-Ghazaly, M.A., Okpanyi, S.N., Kelber, O., Weiser, D., 2006. Mechanisms involved in the gastro-protective effect of STW 5 (Iberogast\u00ae) and its components against ulcers and rebound acidity. Phytomedicine, this issue.","DOI":"10.1016\/j.phymed.2006.03.019"},{"key":"10.1016\/j.phymed.2006.03.012_bib17","unstructured":"Michael, S., Kelber, O., Vinson, B., Nieber, K., 2006. Herbal preparations STW 5 and STW 6 inhibit inflammation-mediated motility disorders in the ileum. Gut, in press."},{"key":"10.1016\/j.phymed.2006.03.012_bib18","doi-asserted-by":"crossref","unstructured":"M\u00fcller, M.H., Liu, C.-Y., Glatzle, J., Weiser, D., Kelber, O., Enck, P., Grundy, D., Kreis, M.E., 2006. STW 5 (Iberogast) reduces afferent sensitivity in the rat small intestine. Phytomedicine, this issue.","DOI":"10.1016\/j.phymed.2006.03.014"},{"key":"10.1016\/j.phymed.2006.03.012_bib8","first-page":"24","article-title":"Funktionelle Gastroenteropathien im therapeutischen Blindvergleich von Metoclopramid mit dem Phytopharmakon Iberogast","volume":"2","author":"Nikolay","year":"1984","journal-title":"Gastro-Entero-Hepatologie"},{"key":"10.1016\/j.phymed.2006.03.012_bib9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.17660\/ActaHortic.1993.332.29","article-title":"Gastrointestinal motility modulation with Iberogast","volume":"332","author":"Okpanyi","year":"1993","journal-title":"Acta Hortic."},{"key":"10.1016\/j.phymed.2006.03.012_bib10","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/sj.bjp.0702665","article-title":"Pharmacological characterization of 5-HT4 receptors mediating relaxation of canine isolated rectum circular smooth muscle","volume":"127","author":"Prins","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phymed.2006.03.012_bib19","doi-asserted-by":"crossref","unstructured":"Pilichiewicz, A.N., Horowitz, M., Russo, A., Maddox, A.F., Jones, K.L., Schemann, M., Holtmann, G., Feinle-Bisset, C., 2006. Effects of Iberogast\u00ae on proximal gastric volume, antropyloroduodenal (APD) motility and gastric emptying in healthy men. Neurogastroenterol. Motility, in press.","DOI":"10.1111\/j.1572-0241.2007.01142.x"},{"key":"10.1016\/j.phymed.2006.03.012_bib12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1055\/s-2002-32130","article-title":"A randomised clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia","volume":"40","author":"Roesch","year":"2002","journal-title":"Z. Gastroenterol."},{"key":"10.1016\/j.phymed.2006.03.012_bib21","unstructured":"R\u00f6sch, W., Vinson, B., Gundermann, K.H., Holtman, G., 2006. Clinical efficacy and safety of STW 5 \u2013 a review. Phytomedicine, this issue."},{"issue":"Suppl. 1","key":"10.1016\/j.phymed.2006.03.012_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000068645","article-title":"Iberogast: Eine moderne phytotherapeutische Arzneimittelkombination zur behandlung funktioneller Erkrankungen des Magen-Darm-Trakts (Dyspepsie, Colon irritabile) \u2013 von der Pflanzenheilkunde zur \u201cEvidence Based Phytotherapy\u201d. Eine systematische \u00dcbersicht","volume":"9","author":"Saller","year":"2002","journal-title":"Forsch Komlement\u00e4rmed Klass Naturheilk"},{"key":"10.1016\/j.phymed.2006.03.012_bib20","doi-asserted-by":"crossref","unstructured":"Schemann, M., Hohenester, B., R\u00fchl, A., 2006. Region-specific effects of STW 5 and its components in gastric fundus\/corpus and antrum. Phytomedicine, this issue.","DOI":"10.1016\/j.phymed.2006.03.020"},{"key":"10.1016\/j.phymed.2006.03.012_bib14","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2165\/00003495-200363090-00003","article-title":"New developments in the treatment of functional dyspepsia","volume":"63","author":"Stanghellini","year":"2003","journal-title":"Drugs"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711306000717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711306000717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,21]],"date-time":"2019-04-21T01:19:57Z","timestamp":1555809597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711306000717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":20,"alternative-id":["S0944711306000717"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2006.03.012","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}